68 related articles for article (PubMed ID: 12738994)
1. Physiological and chemical inducers of tissue factor pathway inhibitor-2 in human glioma cells.
Konduri SD; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
Int J Oncol; 2003 Jun; 22(6):1277-83. PubMed ID: 12738994
[TBL] [Abstract][Full Text] [Related]
2. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas.
Konduri SD; Osman FA; Rao CN; Srinivas H; Yanamandra N; Tasiou A; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Kouraklis G; Rao JS
Oncogene; 2002 Jan; 21(6):921-8. PubMed ID: 11840337
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
4. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
Konduri SD; Rao CN; Chandrasekar N; Tasiou A; Mohanam S; Kin Y; Lakka SS; Dinh D; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
Oncogene; 2001 Oct; 20(47):6938-45. PubMed ID: 11687973
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
8. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.
Hubé F; Reverdiau P; Iochmann S; Rollin J; Cherpi-Antar C; Gruel Y
Biol Chem; 2003 Jul; 384(7):1029-34. PubMed ID: 12956419
[TBL] [Abstract][Full Text] [Related]
10. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
12. Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors.
Siegling S; Thyzel E; Glahn J; Kleesiek K; Götting C
Ann Hematol; 2006 Jan; 85(1):32-7. PubMed ID: 16247609
[TBL] [Abstract][Full Text] [Related]
13. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
15. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
16. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
17. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase.
Zelko IN; Folz RJ
Free Radic Biol Med; 2004 Oct; 37(8):1256-71. PubMed ID: 15451065
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
19. MUC5AC mucin gene regulation in pancreatic cancer cells.
Kato S; Hokari R; Crawley S; Gum J; Ahn DH; Kim JW; Kwon SW; Miura S; Basbaum CB; Kim YS
Int J Oncol; 2006 Jul; 29(1):33-40. PubMed ID: 16773182
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
